Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 5/20 | 0.36 |
| ▸ | USP14 | P54578 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 4/20 | 0.33 |
| ▸ | MAOA | P21397 | 5/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21414227 | 0.93 | ALDH1A1 (0.39) | ALDH1A1CYP2A6GRM5USP14MAOB | |
| SCHEMBL19912340 | 0.89 | ALDH1A1 (0.38) | ALDH1A1CYP2A6GRM5MAOBMAOA | |
| SCHEMBL19912484 | 0.88 | AR (0.39) | ALDH1A1GRM5 | |
| SCHEMBL21414253 | 0.88 | GRM5 (0.37) | ALDH1A1CYP2A6GRM5 | |
| SCHEMBL23299808 | 0.88 | ALDH1A1 (0.35) | ALDH1A1CYP2A6GRM5USP14 | |
| SCHEMBL19913267 | 0.88 | ALDH1A1 (0.35) | ALDH1A1CYP2A6GRM5USP14MAOB | |
| SCHEMBL19912468 | 0.88 | RXRA (0.36) | ALDH1A1CYP2A6GRM5USP14 | |
| SCHEMBL19912348 | 0.85 | PDE9A (0.37) | ALDH1A1CYP2A6GRM5 | |
| SCHEMBL21546695 | 0.85 | CLK4 (0.37) | ALDH1A1 | |
| SCHEMBL19913138 | 0.85 | MAPK14 (0.36) | ALDH1A1GRM5USP14CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | ALDH1A1 817/4885CYP2A6 1990/4885GRM5 4185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.